Gp100 (25-33), human peptide
Not For Human Use, Lab Use Only.
Cat.#: 319816
Special Price 101.70 USD
-
Product Name
Gp100 (25-33), human peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
H-KVPRNQDWL-OH
-
Sequence
H-Lys-Val-Pro-Arg-Asn-Gln-Asp-Trp-Leu-OH
-
Length (aa)
9
-
Peptide Purity (HPLC)
95.02%
-
Molecular Formula
C52H82N16O14
-
Molecular Weight
1155.3
-
CAS No.
212370-40-6
-
Source
Synthetic
-
Form
Powder
-
Description
The Gp100 (25-33), human peptide is a 9-amino acid epitope (KVPRNQDWL) derived from the glycoprotein 100 (gp100) melanoma-associated antigen. This peptide is restricted by the MHC class I molecule H-2Db and serves as a target for cytotoxic T lymphocytes (CTLs). The human version of this peptide exhibits significantly higher binding affinity to H-2Db compared to its murine counterpart (EGSRNQDWL), due to differences in the three NH2-terminal amino acids. This enhanced binding results in greater stability of peptide-MHC complexes and more efficient T cell recognition.
Structural analysis reveals that the human Gp100 (25-33) peptide contains optimal anchor residues at positions 5 (N) and 9 (L) for H-2Db binding. The NH2-terminal residues (KVP in human vs EGS in mouse) contribute to the differential MHC binding affinity, with the human peptide showing approximately 100-fold greater stabilization of H-2Db molecules. The core sequence RNQDWL (positions 4-9) represents the TCR contact region, as substitutions in these positions abrogate T cell recognition while modifications in the NH2-terminal residues maintain immunogenicity.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K, Carroll MW, Liu C, Moss B, Rosenberg SA, Restifo NP. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med. 1998 Jul 20;188(2):277-86. doi: 10.1084/jem.188.2.277. PMID: 9670040; PMCID: PMC2212458.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"